Si prevede che il mercato globale dell'analisi delle urine crescerà a un CAGR superiore al 7,2% dal 2022 al 2029. Si prevede che raggiungerà oltre 6,1 miliardi di USD entro il 2029 dai 3,2 miliardi di USD del 2020.
L'analisi delle urine è una tecnica comoda ed efficace per analizzare campioni di urina per identificare varie infezioni e malattie croniche come diabete, infezioni del tratto urinario e malattie renali . Questo metodo diagnostico comprende una gamma completa di esami visivi, microscopici e chimici volti a rilevare cellule, proteine, livelli di creatinina e varie sostanze come cristalli all'interno dell'urina, aiutando nell'identificazione di diverse malattie.
Durante le fasi iniziali della pandemia di COVID-19, il mercato dell'analisi delle urine ha subito moderate interruzioni attribuibili alla riduzione dei tassi di ospedalizzazione e al calo delle vendite di test di analisi delle urine. Le severe misure di blocco a livello nazionale implementate dai governi per contenere la trasmissione virale hanno ridotto l'accesso degli individui ai servizi diagnostici e sanitari, con conseguente diminuzione della domanda di prodotti diagnostici. Tuttavia, è stata osservata una ripresa delle attività di test in seguito all'allentamento delle restrizioni di movimento in vari paesi. Inoltre, la crescente importanza dell'analisi delle urine nell'identificazione delle complicazioni post-COVID-19, tra cui lesioni renali e tubulari acute, ha contribuito all'espansione del mercato. Uno studio condotto dalla Columbia University ha evidenziato il marcatore di lesione renale-1 (KIM-1) e l'NGAL urinario come biomarcatori sensibili per la rilevazione di lesioni tubulari e renali tra i pazienti.
Urinalysis finds extensive utility in the diagnosis and management of conditions such as kidney and liver diseases, enabling clinicians to evaluate chemical compound levels within urine samples. These factors are anticipated to underpin market growth. Moreover, the heightened prevalence of diseases, substantial patient demographics, enhancements in healthcare infrastructure, escalating disposable incomes, and burgeoning medical tourism in emerging economies are pivotal factors contributing to the enhancement of laboratory facilities, thus fostering market advancement.
The urinalysis market is segmented into type, application and end user. The types are sub segmented in Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers. In normal urinalysis, a dipstick is a fundamental diagnostic instrument used to diagnose pathological alterations in a patient's urine. A typical urine test strip may contain up to ten separate chemical pads or reagents that react (change color) when dipped in and subsequently removed from a urine sample. After dipping, the test can often be read in as little as 60 to 120 seconds, while certain tests take more time. Urine testing using multiparameter strips is the first step in diagnosing a wide range of disorders. Home pregnancy tests are incredibly popular, as evidenced by the fact that one-third of all women have used them at some point in their lives. The FDA approves these items as devices, and during the premarket approval process, the accuracy of each test is evaluated against varied levels of hCG (human chorionic gonadotropin), the pregnancy hormone.
A urinalysis test is used to look for abnormalities in the appearance or composition of the urine. It is frequently used for screening, diagnosing, and monitoring a variety of medical disorders. Screening tests discover health problems before symptoms arise, allowing for early treatment. Because certain liver and kidney problems do not produce symptoms at first, a urinalysis test is routinely used to assess the health of these organs. Urinalysis can also be performed to screen for underlying health issues during a prenatal visit or a pre-surgery evaluation. In these circumstances, urinalysis might be used to screen for previously undiscovered health conditions in order to limit the risk of future consequences.
The process of determining the cause of symptoms is known as diagnosis. When a person begins to notice changes in urine or other symptoms that may be related to liver or kidney disorders, a doctor may advise urinalysis to assist in discovering the cause. Urinalysis can aid in the detection of urinary tract infections (UTIs) and other diseases that influence urinary system function. Monitoring entails tests that track the progression of a person's condition. Urinalysis tests may be performed on a regular basis to determine how effectively treatment is working or if the severity of a problem has altered. The ease of access and greater health coverage for hospital-based healthcare services from various private and group insurance plans are some of the primary factors contributing to the hospitals & clinics segment having the greatest share. Urinalysis testing is utilized as a first-line diagnostic tool in the identification of various metabolic disorders and urinary tract infections (UTIs). It is also used as a disease management tool to treat chronic conditions such as diabetes, Chronic Kidney Disease (CKD), and urinary bladder cancer. Rising renal disorders as a result of changing food consumption habits, as well as growing concerns from the senior population, are among the primary business drivers.The major market players include: Arkray Inc.,Beckman Coulter Inc.,Roche Diagnostics,Siemens Healthcare, Sysmex Corporation, Elektronika KFT., Acon Laboratories Inc., Bio-Rad Laboratories Inc., Mindray Medical International Limited, URIT Medical Electronic Group Co. Ltd. and Others.
The urinalysis market is divided into major regions- North America, Europe, South America, Asia Pacific, and middle east & Africa. North America is the largest regional segment in 2021. Growing penetration of electric cars was the primary factor driving product demand. Furthermore, the growing regulatory support for reducing vehicular emissions is projected to have a favorable impact on growth.
The global urinalysis market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is estimated to hold the highest market share of the urinalysis market during the forecast period due to factors such as increasing chronic illness prevalence, increased research efforts in the field of urinalysis, and expanding urinalysis awareness among the public. In the coming years, Asia Pacific and Latin America are expected to expand at a faster rate than the rest of the world. Some of the reasons projected to drive market expansion include increased adoption of advanced urine analyzers and a growing geriatric population that is more susceptible to chronic diseases. The Middle East and Africa market is expected to increase significantly by the end of the forecast period.
[caption id="attachment_5993" align="alignnone" width="680"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.